Sedana Medical has been approved for trading on Nasdaq Stockholm
Nasdaq Stockholm's Listing Committee has today informed that Sedana Medical AB's (publ) (the "Company" or "Sedana Medical") application for admission to trading of the Company's shares on Nasdaq Stockholm has been approved. The approval is subject to customary conditions being met, including that a prospectus is approved and registered by the Swedish Financial Supervisory Authority (the “SFSA”). The first day of trading on Nasdaq Stockholm is scheduled for 25 January 2023 and the last day of trading on Nasdaq First North Growth Market is scheduled for 24 January 2023.“Over the last years,